- Home
- NSYS vs COEP Comparison
NSYS vs COEP Comparison
Compare NSYS & COEP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NSYS
- COEP
- Stock Information
- Founded
- NSYS 1981
- COEP 2017
- Country
- NSYS United States
- COEP United States
- Employees
- NSYS N/A
- COEP N/A
- Industry
- NSYS Industrial Machinery/Components
- COEP Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- NSYS Technology
- COEP Health Care
- Exchange
- NSYS Nasdaq
- COEP Nasdaq
- Market Cap
- NSYS 29.0M
- COEP 32.4M
- IPO Year
- NSYS N/A
- COEP N/A
- Fundamental
- Price
- NSYS $10.50
- COEP $10.52
- Analyst Decision
- NSYS
- COEP
- Analyst Count
- NSYS 0
- COEP 0
- Target Price
- NSYS N/A
- COEP N/A
- AVG Volume (30 Days)
- NSYS 5.2K
- COEP 109.2K
- Earning Date
- NSYS 03-19-2025
- COEP 03-25-2025
- Dividend Yield
- NSYS N/A
- COEP N/A
- EPS Growth
- NSYS 109.80
- COEP N/A
- EPS
- NSYS 1.55
- COEP N/A
- Revenue
- NSYS $135,567,000.00
- COEP N/A
- Revenue This Year
- NSYS N/A
- COEP N/A
- Revenue Next Year
- NSYS N/A
- COEP N/A
- P/E Ratio
- NSYS $6.76
- COEP N/A
- Revenue Growth
- NSYS N/A
- COEP N/A
- 52 Week Low
- NSYS $9.53
- COEP $2.31
- 52 Week High
- NSYS $19.15
- COEP $13.70
- Technical
- Relative Strength Index (RSI)
- NSYS 51.33
- COEP 48.65
- Support Level
- NSYS $9.97
- COEP $9.27
- Resistance Level
- NSYS $11.00
- COEP $12.95
- Average True Range (ATR)
- NSYS 0.54
- COEP 1.59
- MACD
- NSYS 0.05
- COEP -0.33
- Stochastic Oscillator
- NSYS 50.85
- COEP 38.56
About NSYS Nortech Systems Incorporated
Nortech Systems Inc is a United States-based electronic manufacturing services company. It offers value-added engineering, technical and manufacturing services and support including project management, design, testing, prototyping, manufacturing, supply chain management, and post-market services. The company's manufacturing and engineering services include complete medical devices, printed circuit board assemblies, wire and cable assemblies, and complex higher-level electro-mechanical assemblies. It operates in the Medical, Aerospace, Defense and Industrial markets with key revenue coming from Medical device and product manufacturing and related engineering services.
About COEP Coeptis Therapeutics Holdings Inc.
Coeptis Therapeutics Holdings Inc is a biopharmaceutical company developing cell therapy platforms for patients with cancer. The company's product portfolio consists of multi-antigen CAR T technology licensed from the University of Pittsburgh (SNAP-CAR), a cell therapy technology (CD38-GEAR-NK), and an in vitro diagnostic (CD38-Diagnostic) targeting CD38-related cancers, which the company is developing with VyGen-Bio and medical researchers at the Karolinska Institutet.